On May 9, 2024 Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox platform, reported that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024 (Press release, Rakuten Medical, MAY 9, 2024, View Source [SID1234643091]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The poster presentation will showcase the updated safety and efficacy findings from an interim evaluation of Rakuten Medical’s open-label Phase 1b/2 study (ASP-1929-181/ClinicalTrials.gov Identifier: NCT04305795) of photoimmunotherapy using ASP-1929 in combination with anti-PD-1 therapy in recurrent or metastatic head and neck squamous cell carcinoma.
Rakuten Medical will also have a booth in the Exhibit Hall. The Company medical team will be pleased to welcome ASCO (Free ASCO Whitepaper) participants at booth #12118.
Rakuten Medical’s Poster Presentation
Abstract Title: Recent safety and efficacy findings from a phase 1b/2 open-label combination study of ASP-1929 photoimmunotherapy with anti-PD-1 therapy in EGFR-expressing advanced head and neck squamous cell carcinoma (HNSCC)
Abstract Number: 6083
Abstract Link: View Source
Session Name: Poster Session – Head and Neck Cancer
Session Date: Sunday, June 2, 2024
Session Time: 9:00 a.m. – 12:00 p.m., CDT
First Author: David M. Cognetti, Department of Otolaryngology – Head and Neck Surgery, Thomas Jefferson University, US
Location: Exhibit Hall A, Poster Board #399
Rakuten Medical Booth
Location: Exhibit Hall A, Booth #12118
Exhibit Date: Saturday – Monday, June 1 – 3, 2024
In addition, a research team of Japanese physicians will present a poster on the latest findings from a multi-institutional observation study evaluating the efficacy and safety of photoimmunotherapy for recurrent nasopharyngeal cancer in clinical practice in Japan.
Poster Presentation by Japanese Physicians
Abstract Title: Photoimmunotherapy in nasopharyngeal carcinoma recurrence
Abstract Number: 6068
Abstract Link: View Source
Session Name: Poster Session – Head and Neck Cancer
Session Date: Sunday, June 2, 2024
Session Time: 9:00 a.m. – 12:00 p.m., CDT
First Author: Takeshi Shinozaki, Department of Head and Neck Surgery, National Cancer Center Hospital East, Japan
Location: Exhibit Hall A, Poster Board #384
The full abstracts will be available on the ASCO (Free ASCO Whitepaper) Annual Meeting website.
For more information and update, follow Rakuten Medical on LinkedIn or visit Rakuten Medical’s booth at ASCO (Free ASCO Whitepaper) 2024.